STRONTIUM 2-((4,5-DIHYDRO-3-METHYL-5-OXO-1-(3-SULFOPHENYL)-1H-PYRAZOL-4-YL)-1-NAPHTHALENESULFONATE
UNII S76S7MWO9J
Substance Identification & Data
This profile provides standardized clinical and technical data for Strontium 2-((4,5-dihydro-3-methyl-5-oxo-1-(3-sulfophenyl)-1h-pyrazol-4-yl)-1-naphthalenesulfonate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) S76S7MWO9J.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 250640-48-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C20H14N4O7S2.Sr DBZAHMWYWOWLGV-QUABFQRHSA-L Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Strontium 2-((4,5-dihydro-3-methyl-5-oxo-1-(3-sulfophenyl)-1h-pyrazol-4-yl)-1-naphthalenesulfonate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.